A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors.
Jan 17, 2019
0
4
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva. The discovery offers a parameter for predicting progression of ...
Dec 5, 2018
0
9
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Sep 14, 2018
0
0
A recent paper published in the scientific journal Cell gives an unprecedented insight into the metabolic interactions that occur throughout the body over 24 hours. As part of a large-scale study, the authors constructed ...
Sep 7, 2018
0
0
A research team led by USC scientists has developed a new way to identify molecular markers of breast cancer tumors, a potentially life-saving breakthrough that could lead to better treatment for millions of women.
Sep 6, 2018
0
9
An international team of researchers including USC scientists has found scores of new genetic markers in DNA code that increase prostate cancer riskâpowerful knowledge likely to prove useful to detect and prevent the disease.
Jun 11, 2018
0
126
A group of researchers from Mayo Clinic and Exact Sciences Corporation have completed a phase II study comparing a set of DNA markers to alpha fetoprotein as a method to test for liver cancer. The researchers presented their ...
Jun 6, 2018
0
61
Innate or acquired resistance to current standard-of-care therapies is a major hindrance to successful chemotherapeutic intervention. There is a critical need to elucidate the underlying mechanisms responsible for chemoresistance ...
Mar 1, 2018
0
3
Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.
Jan 9, 2018
0
1
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers ...
Nov 1, 2017
0
4
